A judge has dismissed a lawsuit brought by Human Longevity against the J. Craig Venter Institute.
Human Longevity had filed the suit in July, alleging the misappropriation of trade secrets by Craig Venter, who founded both the company and the institute.
Using biorepository strains, researchers from the J. Craig Venter Institute and elsewhere profiled Zika virus consensus sequences, variant patterns, and phylogenetics.
Human Longevity alleges that Craig Venter stole trade secrets in a lawsuit filed against the J. Craig Venter Institute.
HLI claims that upon his termination in May, Venter took a company-owned laptop and is using HLI trade secrets to build a competing business at JCVI.
Craig Venter is retiring from Human Longevity to return to the research institution that bears his name, the San Diego Union-Tribune reports.
In PLOS this week: PCR-based approach to diagnose eye infection in cats and dogs, genomic analysis of Chinook salmon, and more.
Researchers detected excess genetic risk and/or misclassification when profiling ClinVar variants in ACMG-59 and OrphaNet genes using genome and exome sequences.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.
Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.
University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.
NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.
In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.